Lifesciences Equipment Leasing Market in US 2024-2028

Report
162 Pages
March 2024
Region: United States
TechNavio
ID: 5949772

The lifesciences equipment leasing market in US is forecasted to grow by USD 685.99 mn during 2023-2028, accelerating at a CAGR of 7.7% during the forecast period. The report on the lifesciences equipment leasing market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high cost of life sciences equipment, growing demand from low-budget research institutions, and continuous technological advancements coupled with shorter lifecycles.

The lifesciences equipment leasing market in US is segmented as below:

By End-user

Pharmaceutical companies
Biopharmaceutical companies

By Product

Chromatography systems
Centrifuges
Mass spectrometry
Incubators
Microscope and others

By Type

Capital lease
Operating lease
Hire purchase

This study identifies the uberization of life sciences equipment leasing as one of the prime reasons driving the lifesciences equipment leasing market in US growth during the next few years. Also, integration of digital platforms by life sciences equipment lessors and rising demand for full leasing of life sciences equipment will lead to sizable demand in the market.

The report on the lifesciences equipment leasing market in US covers the following areas:

Lifesciences equipment leasing market in US sizing
Lifesciences equipment leasing market in US forecast
Lifesciences equipment leasing market in US industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading lifesciences equipment leasing market in US vendors that include Agilent Technologies Inc., American Capital Group Inc., Avtech Financial Group of companies, Commercial Finance and Leasing Cardiff Bank Inc., Crestmont Capital LLC, CSC Leasing Co., Danaher Corp., Excedr Inc., GeNESIS Commercial Capital, GenTech Scientific LLC, Olympus Corp., Peoples Bancorp Inc., Rabobank Group, Royal Bank of Canada, Scientific Equipment Source Inc., Siemens AG, STINSON LLP, Sun South Equipment Leasing Inc., Thermo Fisher Scientific Inc., and Waters Corp.. Also, the lifesciences equipment leasing market in US analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Country Market Characteristics
Exhibit 04: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 08: Parent market
Exhibit 09: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 10: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 11: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 12: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 13: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 14: Chart on US: Year-over-year growth 2023-2028 (%)
Exhibit 15: Data Table on US: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Lifesciences equipment leasing market in US 2018 - 2022
Exhibit 16: Historic Market Size - Data Table on lifesciences equipment leasing market in US 2018 - 2022 ($ million)
4.2 End-user Segment Analysis 2018 - 2022
Exhibit 17: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.3 Product Segment Analysis 2018 - 2022
Exhibit 18: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.4 Type Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 20: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 21: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 22: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 23: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 24: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 25: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 26: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

6.1 Market segments
Exhibit 27: Chart on End-user - Market share 2023-2028 (%)
Exhibit 28: Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
Exhibit 29: Chart on Comparison by End-user
Exhibit 30: Data Table on Comparison by End-user
6.3 Pharmaceutical companies - Market size and forecast 2023-2028
Exhibit 31: Chart on Pharmaceutical companies - Market size and forecast 2023-2028 ($ million)
Exhibit 32: Data Table on Pharmaceutical companies - Market size and forecast 2023-2028 ($ million)
Exhibit 33: Chart on Pharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibit 34: Data Table on Pharmaceutical companies - Year-over-year growth 2023-2028 (%)
6.4 Biopharmaceutical companies - Market size and forecast 2023-2028
Exhibit 35: Chart on Biopharmaceutical companies - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Data Table on Biopharmaceutical companies - Market size and forecast 2023-2028 ($ million)
Exhibit 37: Chart on Biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibit 38: Data Table on Biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by End-user
Exhibit 39: Market opportunity by End-user ($ million)
Exhibit 40: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Product

7.1 Market segments
Exhibit 41: Chart on Product - Market share 2023-2028 (%)
Exhibit 42: Data Table on Product - Market share 2023-2028 (%)
7.2 Comparison by Product
Exhibit 43: Chart on Comparison by Product
Exhibit 44: Data Table on Comparison by Product
7.3 Chromatography systems - Market size and forecast 2023-2028
Exhibit 45: Chart on Chromatography systems - Market size and forecast 2023-2028 ($ million)
Exhibit 46: Data Table on Chromatography systems - Market size and forecast 2023-2028 ($ million)
Exhibit 47: Chart on Chromatography systems - Year-over-year growth 2023-2028 (%)
Exhibit 48: Data Table on Chromatography systems - Year-over-year growth 2023-2028 (%)
7.4 Centrifuges - Market size and forecast 2023-2028
Exhibit 49: Chart on Centrifuges - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Data Table on Centrifuges - Market size and forecast 2023-2028 ($ million)
Exhibit 51: Chart on Centrifuges - Year-over-year growth 2023-2028 (%)
Exhibit 52: Data Table on Centrifuges - Year-over-year growth 2023-2028 (%)
7.5 Mass spectrometry - Market size and forecast 2023-2028
Exhibit 53: Chart on Mass spectrometry - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Data Table on Mass spectrometry - Market size and forecast 2023-2028 ($ million)
Exhibit 55: Chart on Mass spectrometry - Year-over-year growth 2023-2028 (%)
Exhibit 56: Data Table on Mass spectrometry - Year-over-year growth 2023-2028 (%)
7.6 Incubators - Market size and forecast 2023-2028
Exhibit 57: Chart on Incubators - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Data Table on Incubators - Market size and forecast 2023-2028 ($ million)
Exhibit 59: Chart on Incubators - Year-over-year growth 2023-2028 (%)
Exhibit 60: Data Table on Incubators - Year-over-year growth 2023-2028 (%)
7.7 Microscope and others - Market size and forecast 2023-2028
Exhibit 61: Chart on Microscope and others - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Data Table on Microscope and others - Market size and forecast 2023-2028 ($ million)
Exhibit 63: Chart on Microscope and others - Year-over-year growth 2023-2028 (%)
Exhibit 64: Data Table on Microscope and others - Year-over-year growth 2023-2028 (%)
7.8 Market opportunity by Product
Exhibit 65: Market opportunity by Product ($ million)
Exhibit 66: Data Table on Market opportunity by Product ($ million)

8 Market Segmentation by Type

8.1 Market segments
Exhibit 67: Chart on Type - Market share 2023-2028 (%)
Exhibit 68: Data Table on Type - Market share 2023-2028 (%)
8.2 Comparison by Type
Exhibit 69: Chart on Comparison by Type
Exhibit 70: Data Table on Comparison by Type
8.3 Capital lease - Market size and forecast 2023-2028
Exhibit 71: Chart on Capital lease - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Capital lease - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Capital lease - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Capital lease - Year-over-year growth 2023-2028 (%)
8.4 Operating lease - Market size and forecast 2023-2028
Exhibit 75: Chart on Operating lease - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Operating lease - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Operating lease - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Operating lease - Year-over-year growth 2023-2028 (%)
8.5 Hire purchase - Market size and forecast 2023-2028
Exhibit 79: Chart on Hire purchase - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Hire purchase - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Hire purchase - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Hire purchase - Year-over-year growth 2023-2028 (%)
8.6 Market opportunity by Type
Exhibit 83: Market opportunity by Type ($ million)
Exhibit 84: Data Table on Market opportunity by Type ($ million)

9 Customer Landscape

9.1 Customer landscape overview
Exhibit 85: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 86: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 87: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 88: Overview on factors of disruption
11.4 Industry risks
Exhibit 89: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 90: Vendors covered
12.2 Market positioning of vendors
Exhibit 91: Matrix on vendor position and classification
12.3 Agilent Technologies Inc.
Exhibit 92: Agilent Technologies Inc. - Overview
Exhibit 93: Agilent Technologies Inc. - Business segments
Exhibit 94: Agilent Technologies Inc. - Key news
Exhibit 95: Agilent Technologies Inc. - Key offerings
Exhibit 96: Agilent Technologies Inc. - Segment focus
12.4 American Capital Group Inc.
Exhibit 97: American Capital Group Inc. - Overview
Exhibit 98: American Capital Group Inc. - Product/Service
Exhibit 99: American Capital Group Inc. - Key offerings
12.5 Avtech Financial Group of companies
Exhibit 100: Avtech Financial Group of companies - Overview
Exhibit 101: Avtech Financial Group of companies - Product/Service
Exhibit 102: Avtech Financial Group of companies - Key offerings
12.6 Commercial Finance and Leasing Cardiff Bank Inc.
Exhibit 103: Commercial Finance and Leasing Cardiff Bank Inc. - Overview
Exhibit 104: Commercial Finance and Leasing Cardiff Bank Inc. - Product/Service
Exhibit 105: Commercial Finance and Leasing Cardiff Bank Inc. - Key offerings
12.7 CSC Leasing Co.
Exhibit 106: CSC Leasing Co. - Overview
Exhibit 107: CSC Leasing Co. - Product/Service
Exhibit 108: CSC Leasing Co. - Key offerings
12.8 Danaher Corp.
Exhibit 109: Danaher Corp. - Overview
Exhibit 110: Danaher Corp. - Business segments
Exhibit 111: Danaher Corp. - Key news
Exhibit 112: Danaher Corp. - Key offerings
Exhibit 113: Danaher Corp. - Segment focus
12.9 Excedr Inc.
Exhibit 114: Excedr Inc. - Overview
Exhibit 115: Excedr Inc. - Product/Service
Exhibit 116: Excedr Inc. - Key offerings
12.10 Olympus Corp.
Exhibit 117: Olympus Corp. - Overview
Exhibit 118: Olympus Corp. - Business segments
Exhibit 119: Olympus Corp. - Key news
Exhibit 120: Olympus Corp. - Key offerings
Exhibit 121: Olympus Corp. - Segment focus
12.11 Rabobank Group
Exhibit 122: Rabobank Group - Overview
Exhibit 123: Rabobank Group - Business segments
Exhibit 124: Rabobank Group - Key offerings
Exhibit 125: Rabobank Group - Segment focus
12.12 Royal Bank of Canada
Exhibit 126: Royal Bank of Canada - Overview
Exhibit 127: Royal Bank of Canada - Business segments
Exhibit 128: Royal Bank of Canada - Key offerings
Exhibit 129: Royal Bank of Canada - Segment focus
12.13 Scientific Equipment Source Inc.
Exhibit 130: Scientific Equipment Source Inc. - Overview
Exhibit 131: Scientific Equipment Source Inc. - Product/Service
Exhibit 132: Scientific Equipment Source Inc. - Key offerings
12.14 Siemens AG
Exhibit 133: Siemens AG - Overview
Exhibit 134: Siemens AG - Business segments
Exhibit 135: Siemens AG - Key news
Exhibit 136: Siemens AG - Key offerings
Exhibit 137: Siemens AG - Segment focus
12.15 STINSON LLP
Exhibit 138: STINSON LLP - Overview
Exhibit 139: STINSON LLP - Product/Service
Exhibit 140: STINSON LLP - Key offerings
12.16 Thermo Fisher Scientific Inc.
Exhibit 141: Thermo Fisher Scientific Inc. - Overview
Exhibit 142: Thermo Fisher Scientific Inc. - Business segments
Exhibit 143: Thermo Fisher Scientific Inc. - Key news
Exhibit 144: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 145: Thermo Fisher Scientific Inc. - Segment focus
12.17 Waters Corp.
Exhibit 146: Waters Corp. - Overview
Exhibit 147: Waters Corp. - Business segments
Exhibit 148: Waters Corp. - Key news
Exhibit 149: Waters Corp. - Key offerings
Exhibit 150: Waters Corp. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 151: Inclusions checklist
Exhibit 152: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 153: Currency conversion rates for US$
13.4 Research methodology
Exhibit 154: Research methodology
Exhibit 155: Validation techniques employed for market sizing
Exhibit 156: Information sources
13.5 List of abbreviations
Exhibit 157: List of abbreviations

List of Exhibits

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Country Market Characteristics
Exhibits 4: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Vendor Market Positioning
Exhibits 8: Parent market
Exhibits 9: Market Characteristics
Exhibits 10: Offerings of vendors included in the market definition
Exhibits 11: Market segments
Exhibits 12: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 13: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 14: Chart on US: Year-over-year growth 2023-2028 (%)
Exhibits 15: Data Table on US: Year-over-year growth 2023-2028 (%)
Exhibits 16: Historic Market Size - Data Table on lifesciences equipment leasing market in US 2018 - 2022 ($ million)
Exhibits 17: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits 18: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 20: Five forces analysis - Comparison between 2023 and 2028
Exhibits 21: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 22: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 23: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 24: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 25: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 26: Chart on Market condition - Five forces 2023 and 2028
Exhibits 27: Chart on End-user - Market share 2023-2028 (%)
Exhibits 28: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 29: Chart on Comparison by End-user
Exhibits 30: Data Table on Comparison by End-user
Exhibits 31: Chart on Pharmaceutical companies - Market size and forecast 2023-2028 ($ million)
Exhibits 32: Data Table on Pharmaceutical companies - Market size and forecast 2023-2028 ($ million)
Exhibits 33: Chart on Pharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits 34: Data Table on Pharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits 35: Chart on Biopharmaceutical companies - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Data Table on Biopharmaceutical companies - Market size and forecast 2023-2028 ($ million)
Exhibits 37: Chart on Biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits 38: Data Table on Biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits 39: Market opportunity by End-user ($ million)
Exhibits 40: Data Table on Market opportunity by End-user ($ million)
Exhibits 41: Chart on Product - Market share 2023-2028 (%)
Exhibits 42: Data Table on Product - Market share 2023-2028 (%)
Exhibits 43: Chart on Comparison by Product
Exhibits 44: Data Table on Comparison by Product
Exhibits 45: Chart on Chromatography systems - Market size and forecast 2023-2028 ($ million)
Exhibits 46: Data Table on Chromatography systems - Market size and forecast 2023-2028 ($ million)
Exhibits 47: Chart on Chromatography systems - Year-over-year growth 2023-2028 (%)
Exhibits 48: Data Table on Chromatography systems - Year-over-year growth 2023-2028 (%)
Exhibits 49: Chart on Centrifuges - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Data Table on Centrifuges - Market size and forecast 2023-2028 ($ million)
Exhibits 51: Chart on Centrifuges - Year-over-year growth 2023-2028 (%)
Exhibits 52: Data Table on Centrifuges - Year-over-year growth 2023-2028 (%)
Exhibits 53: Chart on Mass spectrometry - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Data Table on Mass spectrometry - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Chart on Mass spectrometry - Year-over-year growth 2023-2028 (%)
Exhibits 56: Data Table on Mass spectrometry - Year-over-year growth 2023-2028 (%)
Exhibits 57: Chart on Incubators - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Data Table on Incubators - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Chart on Incubators - Year-over-year growth 2023-2028 (%)
Exhibits 60: Data Table on Incubators - Year-over-year growth 2023-2028 (%)
Exhibits 61: Chart on Microscope and others - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Data Table on Microscope and others - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Chart on Microscope and others - Year-over-year growth 2023-2028 (%)
Exhibits 64: Data Table on Microscope and others - Year-over-year growth 2023-2028 (%)
Exhibits 65: Market opportunity by Product ($ million)
Exhibits 66: Data Table on Market opportunity by Product ($ million)
Exhibits 67: Chart on Type - Market share 2023-2028 (%)
Exhibits 68: Data Table on Type - Market share 2023-2028 (%)
Exhibits 69: Chart on Comparison by Type
Exhibits 70: Data Table on Comparison by Type
Exhibits 71: Chart on Capital lease - Market size and forecast 2023-2028 ($ million)
Exhibits 72: Data Table on Capital lease - Market size and forecast 2023-2028 ($ million)
Exhibits 73: Chart on Capital lease - Year-over-year growth 2023-2028 (%)
Exhibits 74: Data Table on Capital lease - Year-over-year growth 2023-2028 (%)
Exhibits 75: Chart on Operating lease - Market size and forecast 2023-2028 ($ million)
Exhibits 76: Data Table on Operating lease - Market size and forecast 2023-2028 ($ million)
Exhibits 77: Chart on Operating lease - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on Operating lease - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on Hire purchase - Market size and forecast 2023-2028 ($ million)
Exhibits 80: Data Table on Hire purchase - Market size and forecast 2023-2028 ($ million)
Exhibits 81: Chart on Hire purchase - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on Hire purchase - Year-over-year growth 2023-2028 (%)
Exhibits 83: Market opportunity by Type ($ million)
Exhibits 84: Data Table on Market opportunity by Type ($ million)
Exhibits 85: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 86: Impact of drivers and challenges in 2023 and 2028
Exhibits 87: Overview on Criticality of inputs and Factors of differentiation
Exhibits 88: Overview on factors of disruption
Exhibits 89: Impact of key risks on business
Exhibits 90: Vendors covered
Exhibits 91: Matrix on vendor position and classification
Exhibits 92: Agilent Technologies Inc. - Overview
Exhibits 93: Agilent Technologies Inc. - Business segments
Exhibits 94: Agilent Technologies Inc. - Key news
Exhibits 95: Agilent Technologies Inc. - Key offerings
Exhibits 96: Agilent Technologies Inc. - Segment focus
Exhibits 97: American Capital Group Inc. - Overview
Exhibits 98: American Capital Group Inc. - Product/Service
Exhibits 99: American Capital Group Inc. - Key offerings
Exhibits 100: Avtech Financial Group of companies - Overview
Exhibits 101: Avtech Financial Group of companies - Product/Service
Exhibits 102: Avtech Financial Group of companies - Key offerings
Exhibits 103: Commercial Finance and Leasing Cardiff Bank Inc. - Overview
Exhibits 104: Commercial Finance and Leasing Cardiff Bank Inc. - Product/Service
Exhibits 105: Commercial Finance and Leasing Cardiff Bank Inc. - Key offerings
Exhibits 106: CSC Leasing Co. - Overview
Exhibits 107: CSC Leasing Co. - Product/Service
Exhibits 108: CSC Leasing Co. - Key offerings
Exhibits 109: Danaher Corp. - Overview
Exhibits 110: Danaher Corp. - Business segments
Exhibits 111: Danaher Corp. - Key news
Exhibits 112: Danaher Corp. - Key offerings
Exhibits 113: Danaher Corp. - Segment focus
Exhibits 114: Excedr Inc. - Overview
Exhibits 115: Excedr Inc. - Product/Service
Exhibits 116: Excedr Inc. - Key offerings
Exhibits 117: Olympus Corp. - Overview
Exhibits 118: Olympus Corp. - Business segments
Exhibits 119: Olympus Corp. - Key news
Exhibits 120: Olympus Corp. - Key offerings
Exhibits 121: Olympus Corp. - Segment focus
Exhibits 122: Rabobank Group - Overview
Exhibits 123: Rabobank Group - Business segments
Exhibits 124: Rabobank Group - Key offerings
Exhibits 125: Rabobank Group - Segment focus
Exhibits 126: Royal Bank of Canada - Overview
Exhibits 127: Royal Bank of Canada - Business segments
Exhibits 128: Royal Bank of Canada - Key offerings
Exhibits 129: Royal Bank of Canada - Segment focus
Exhibits 130: Scientific Equipment Source Inc. - Overview
Exhibits 131: Scientific Equipment Source Inc. - Product/Service
Exhibits 132: Scientific Equipment Source Inc. - Key offerings
Exhibits 133: Siemens AG - Overview
Exhibits 134: Siemens AG - Business segments
Exhibits 135: Siemens AG - Key news
Exhibits 136: Siemens AG - Key offerings
Exhibits 137: Siemens AG - Segment focus
Exhibits 138: STINSON LLP - Overview
Exhibits 139: STINSON LLP - Product/Service
Exhibits 140: STINSON LLP - Key offerings
Exhibits 141: Thermo Fisher Scientific Inc. - Overview
Exhibits 142: Thermo Fisher Scientific Inc. - Business segments
Exhibits 143: Thermo Fisher Scientific Inc. - Key news
Exhibits 144: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 145: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 146: Waters Corp. - Overview
Exhibits 147: Waters Corp. - Business segments
Exhibits 148: Waters Corp. - Key news
Exhibits 149: Waters Corp. - Key offerings
Exhibits 150: Waters Corp. - Segment focus
Exhibits 151: Inclusions checklist
Exhibits 152: Exclusions checklist
Exhibits 153: Currency conversion rates for US$
Exhibits 154: Research methodology
Exhibits 155: Validation techniques employed for market sizing
Exhibits 156: Information sources
Exhibits 157: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global lifesciences equipment leasing market in US: Agilent Technologies Inc., American Capital Group Inc., Avtech Financial Group of companies, Commercial Finance and Leasing Cardiff Bank Inc., Crestmont Capital LLC, CSC Leasing Co., Danaher Corp., Excedr Inc., GeNESIS Commercial Capital, GenTech Scientific LLC, Olympus Corp., Peoples Bancorp Inc., Rabobank Group, Royal Bank of Canada, Scientific Equipment Source Inc., Siemens AG, STINSON LLP, Sun South Equipment Leasing Inc., Thermo Fisher Scientific Inc., and Waters Corp..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is uberization of life sciences equipment leasing.'

According to the report, one of the major drivers for this market is the high cost of life sciences equipment.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Agilent Technologies Inc.
American Capital Group Inc.
Avtech Financial Group of companies
Commercial Finance and Leasing Cardiff Bank Inc.
Crestmont Capital LLC
CSC Leasing Co.
Danaher Corp.
Excedr Inc.
GeNESIS Commercial Capital
GenTech Scientific LLC
Olympus Corp.
Peoples Bancorp Inc.
Rabobank Group
Royal Bank of Canada
Scientific Equipment Source Inc.
Siemens AG
STINSON LLP
Sun South Equipment Leasing Inc.
Thermo Fisher Scientific Inc.
Waters Corp.

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2437EUR$2,500USD£2,030GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€3899EUR$4,000USD£3,248GBP

The lifesciences equipment leasing market in US is segmented as below:

By End-user

By Product

By Type

The report on the lifesciences equipment leasing market in US covers the following areas:

Table of Contents

Executive Summary

Companies Mentioned (Partial List)

Related Topics

Related Reports

Healthcare Equipment Leasing Market 2024-2028

Healthcare Equipment Leasing Market - Focused Insights 2024-2029

Storage and Warehousing Leasing Market 2024-2028

Healthcare Equipment Leasing Market Report 2024

Enterprise Asset Leasing Market Report by Asset Type, Leasing Type, Enterprise Size, Industry Vertical, and Region 2024-2032